RELATING TO HARM REDUCTION.

2025 Regular Session Introduced by Nadine Nakamura

House Bill 1114 establishes a sterile needle exchange program in Arkansas, protecting participants and reducing disease spread among drug users, enhancing public health.

Introduced and Pass First Reading.

#departmentofhealth #liability #needs-baseddistribution #non-injectiondruguserparticipation #sterileneedleandsyringeexchangeprogram

Purpose and Intent

House Bill 1114 (HB 1114) aims to enhance harm reduction strategies in Arkansas, particularly focusing on non-injection drug user participation and the establishment of a sterile needle and syringe exchange program. The bill seeks to address public health concerns related to drug use and promote safer practices among drug users to reduce the spread of infectious diseases.

Key Provisions

Sterile Needle and Syringe Exchange Program: The bill proposes the creation of a program that allows for the exchange of used needles and syringes for sterile ones, thereby reducing the risk of disease transmission among drug users.

Non-Injection Drug User Participation: It emphasizes the inclusion of non-injection drug users in harm reduction initiatives, recognizing the need for comprehensive strategies that address various forms of drug use.

Liability Protections: The bill includes provisions to protect individuals and organizations participating in harm reduction efforts from legal liabilities, encouraging broader participation in these programs.

Needs-Based Distribution: It outlines a framework for the needs-based distribution of resources and services to ensure that harm reduction efforts are effectively targeted to communities most in need.

Affected Parties

Drug Users: The primary beneficiaries of this bill are individuals who use drugs, particularly those who may be at risk of contracting or spreading infectious diseases.

Public Health Organizations: Organizations involved in public health and harm reduction will be directly impacted, as they may receive funding and support to implement the proposed programs.

State and Local Governments: The bill will require coordination and collaboration between various levels of government to effectively roll out the harm reduction initiatives.

Procedural Aspects

Introduced: January 13, 2025

Status: The bill has passed its first reading and is currently under consideration by the Joint Budget Committee.

Emergency Clause: An emergency clause has been adopted, indicating that the bill is intended to take effect immediately upon passage to address urgent public health needs.

Timeline: The bill is expected to move through the legislative process quickly, with a focus on implementation by July 1, 2025.

Conclusion

HB 1114 represents a significant step towards improving public health outcomes in Arkansas by implementing harm reduction strategies. By establishing a sterile needle and syringe exchange program and protecting participants from liability, the bill aims to create a safer environment for drug users and reduce the spread of infectious diseases. The successful passage and implementation of this bill could have a profound impact on the state's approach to drug use and public health.

Bill